Transcept Pharmaceuticals transcept.com

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Trancept's remaining product development candidate is TO-2070, a novel rapidly absorbed treatment for acute migraine incorporating dihydroergotamine (DHE) as the active drug, which Transcept has developed through the completion of preclinical safety studies but has not initiated a Phase 1 hu...Show all

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Trancept's remaining product development c...Show all

See All Exits Recent Exits

Phone: 510-215-3500

Fax:

1003 West Cutting Boulevard
Suite 110 Pt. Richmond
Richmond, 94804
California, United States

Transcept Pharmaceuticals - Investments & Acquisitions

Show Real Data Transcept Pharmaceuticals Investments
See all Recent Investments
Date Company Round Amount Co-investors
See all 0 investments